The double pressure reserve (DPR) has recently been shown to have greater prognostic power than metabolic equivalents, heart rate indices, and systolic blood pressure in healthy subjects. It is unclear whether DPR offers any prognostic value in a heart failure population where variables derived from metabolic gas exchange data provide important prognostic information.
INTRODUCTION
Cardiopulmonary exercise testing (CPET) with metabolic gas exchange is a standard test for predicting survival in patients with chronic heart failure (CHF). CHF patients have an impaired response to exercise as shown by a lower peak oxygen uptake [1] and anaerobic threshold than healthy subjects [2] . Patients with CHF also have an increase in the slope relating ventilation (VE) to carbon dioxide production (VCO 2 ), which is also related to survival [3, 4] .
Recently, Rafie and colleagues [5, 6] showed that the double product reserve (DPR) was a better predictor of mortality than metabolic equivalents, maximal heart rate (HR), systolic blood pressure or HR recovery in 1,655 normal men referred for assessment of exercise capacity. To our knowledge, no previous studies have compared the prognostic value of the DPR against traditional predictors of mortality derived from metabolic gas exchange in a heart failure population. The aim of our study was to evaluate the relative prognostic significance of the DPR in patients with CHF.
METHODS
The Hull and East Riding Ethics Committee approved the study, and all patients provided informed consent prior to the study. We recruited consecutive patients referred to a com *Address correspondence to this author at the Carnegie Research Institute, Leeds Metropolitan University, Beckett's Park, Headingley, Leeds, LS6 3QS, UK; Tel: 0113 8123246; E-mail: L.Ingle@leedsmet.ac.uk munity heart failure clinic with symptoms of breathlessness (NYHA functional class II-III) who were found to have left ventricular systolic dysfunction on investigation. Clinical information obtained included past medical history and drug and smoking history. Clinical examination included assessment of body mass index (BMI), heart rate, rhythm, and blood pressure. Patients were excluded if they were unable to walk without assistance from another person (not including mobility aids), or if they were unable to exercise because of non-cardiac limitations such as osteoarthritis or respiratory disease defined as a predicted FEV 1 <70%.
Heart failure (HF) was defined as the presence of current symptoms of HF, or a history of symptoms controlled by ongoing therapy, due to cardiac dysfunction and in the absence of any more likely cause [7] . Left ventricular function was determined from 2D echocardiography and was carried out by one of three trained operators. Left ventricular function was assessed by estimation on a scale of normal, mild, mild-to-moderate, moderate, moderate-to-severe, and severe impairment and was assessed by a second operator blind to the assessment of the first; where there was disagreement on the severity of left ventricular (LV) dysfunction, the echocardiogram was reviewed jointly with the third operator and a consensus reached. Left ventricular ejection fraction (LVEF) was calculated using the Simpson's formula from measurements of end-diastolic and end-systolic volumes on apical 2D views, following the guidelines of Schiller and colleagues [8] and LVSD was diagnosed if LVEF was 45%.
Patients underwent a symptom-limited, treadmill-based maximal CPET using the Bruce protocol modified by the addition of a Stage 0 (2.74 km·h -1 and 0% gradient). Metabolic gas exchange was measured with an Oxycon Delta metabolic cart (VIASYS Healthcare Inc., Philadelphia, PA). Peak oxygen uptake (pVO 2 ) was calculated as the average VO 2 for the final 30s of exercise. The ventilatory anaerobic threshold (VAT) was calculated by the V-slope method [9] . The VE/ VCO 2 ratio was calculated by linear regression analysis using data acquired from the whole test. The peak respiratory exchange ratio (pRER) was calculated as the mean VCO 2 /VO 2 ratio for the final 30s of exercise. Blood pressure (BP) was measured using an automated blood pressure monitor (SunTech Tango, USA). Resting BP and heart rate (HR) were measured following 10 min of rest in a supine position. The DPR was calculated as the product of peak systolic blood pressure and peak heart rate subtracted from the product of resting systolic blood pressure and resting heart rate values.
Statistical Analysis
SPSS (version 14.0) was used to analyse the data. Continuous variables are presented as mean ± SD, and categorical data are presented as percentages. Continuous variables were assessed for normality by the Kolmogorov-Smirnov test. We used Pearson correlation coefficients to calculate association between variables. An independent samples t-test was used to calculate differences between alive and deceased patients at 12 months. An arbitrary level of 5% statistical significance was used throughout (two-tailed).
All survivors were followed for a minimum of 12 months and we therefore give the probability of 12-month survival. All baseline variables ( Table 1) were entered as potential univariate predictors of mortality using Cox analysis. Model building was based on backwards elimination (P-value for entry was <0.05; P-value for removal >0.1). A multivariate Cox proportional hazards model using backwards elimination was used to identify independent predictors of all-cause mortality from the remaining univariate predictors. Our outcome measure was all-cause mortality.
RESULTS
363 patients (mean ± SD; age 74±11 years; 81% males; LVEF 34±6%; peak VO 2 19.0 ± 5.1 mL·kg -1 ·min -1 ;VE/VCO 2 slope 37 ± 9; DPR 10,510 ± 6,046 mmHg·beat -1 ) were in- cluded in the study. Of these, 78% were prescribed ACEinhibitors, 67% beta-blockers, and 73% loop diuretics. Table  1 shows the clinical characteristics of patients included in the study.
Patients who had deceased at 12 months, had lower peak oxygen uptake, exercise duration, peak systolic BP, and peak diastolic BP than alive patients (P <0.05; Table 1 ). There was a weak negative correlation between resting HR and resting systolic BP (r = -0.15; P = 0.004), and a weak correlation between heart rate reserve and systolic BP reserve (r = 0.27; P = 0.0002). The DPR was moderately correlated with peak oxygen uptake (r =0.45; P=0.001; Fig. 1 ) but showed no association with VE/VCO 2 slope (r =-0.08; P=0.157).
During continued follow up, 87 patients died representing a crude death rate of 24%. In surviving patients, the median follow up (inter-quartile range) was 42 (34-50) months. Higher DPR did appear to be related to a better survival, but this effect did not reach statistical significance. By contrast, Kaplan-Meier curves for peak oxygen uptake show a greater separation between quartile ranges (log rank 2 = 27; P = 0.001) than for DPR (log rank 2 = 9; P = 0.65) (Figs. 2 &  3) . Table 1 were included as potential candidate univariate predictors of outcome in a Cox model. Six variables met the inclusion criterion (P<0.1); peak VO 2 , VE/VCO 2 slope, LVEF, age, heart rate (rest), BMI (Table 2) Fig. (1) . Relation between peak oxygen uptake and double pressure reserve in CHF. Fig. (2) . Kaplan-Meier curve showing prognostic value of peak oxygen uptake in CHF. and were included in the Cox multivariate regression model. DPR was not a univariate predictor of mortality (P=0.7; HR=1.0; 95% CI = 0.99-1.0). The strongest predictors of allcause mortality was peak oxygen uptake (HR= 0.87; P<0.001; 95% CI=0.75-0.99) followed by the VE/VCO 2 slope ( Table 3) .
All the variables in

DISCUSSION
The DPR is not an independent predictor of mortality during exercise testing with metabolic gas exchange in patients with CHF. Rafie et al. [6] reported that lower DPR was an independent predictor of cardiovascular mortality in men referred for assessment of potential coronary disease, both in those with established cardiovascular disease and those without. The mean DPR value (10,510 ± 6,046 mmHg·beat -1 ) in our patients was similar to that reported by Rafie [6] in patients with CV disease (10,392 ± 4,846 mmHg·beat -1 ).
The DPR has been shown to be directly related to exercise capacity (METs) and heart rate recovery (HRR), and a DPR of 10,000 mmHg·beat -1 is a strong and independent predictor of CV mortality [6] . A low DPR is a stronger predictor of an increased risk of death than traditional risk factors such as smoking, diabetes, and exercise-related markers such as maximal HR, HRR, or exercise capacity. However, the authors were not able to measure metabolic gas exchange and thus were not able to compare the value of DPP against known predictors of mortality such as peak oxygen uptake and VE/VCO 2 slope [5, 6, 10] . Further, they did not include patients with CHF. We have shown that prognostic markers derived from metabolic gas exchange are more important than DPR in patients with CHF. The double (rate-pressure) product has been used as an estimate of the maximal performance of the left ventricle during exercise testing [6] , and is an indirect marker of myocardial oxygen consumption [11] . However, it does not have any prognostic value in our cohort of CHF patients.
Limitations
We only evaluated the prognostic impact of DPR against all-cause mortality. We were unable to assess cause-specific mortality in our subset of CHF patients.
CONCLUSION
In CHF, the DPR is not an independent predictor of mortality. Traditional prognostic markers derived from metabolic gas exchange including peak VO 2 and the VE/VCO 2 slope are more important. We recommend that exercise testing with metabolic gas exchange should be incorporated into clinical practice in order to improve prognostic predictive power in patients with CHF.
